Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is April 25, 2024.
All times in Eastern Daylight Time.
-
Riassunto: BeiGene, innovatore oncologico globale, presenta nuovi dati del suo portafoglio sui tumori solidi ed ematologici al congresso annuale 2024 dell'ASCOBASILEA, Svizzera, PECHINO e CAMBRIDGE, Mass.--(BUSINESS WIRE)--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), società oncologica globale, oggi ha annunciato che condividerà i risultati de... more »
-
Globaler Onkologie-Innovator BeiGene präsentiert auf der ASCO-Jahrestagung 2024 neue Daten aus dem gesamten Portfolio für Hämatologie und solide TumoreBASEL, Schweiz & PEKING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), ein globales Onkologieunternehmen, gab heute bekannt, dass es auf der Jahrestagu... more »
-
BeiGene, innovateur mondial en oncologie, présente de nouvelles données sur l’ensemble de son portefeuille en hématologie et en tumeurs solides lors de la réunion annuelle de l’ASCO 2024BÂLE, Suisse et PÉKIN et CAMBRIDGE, Massachusetts--(BUSINESS WIRE)--BeiGene, Ltd. (NASDAQ : BGNE ; HKEX : 06160 ; SSE : 688235), une société mondiale d’oncologie, a annoncé aujourd’hui qu’elle part... more »
-
Resumen: BeiGene, innovador internacional en oncología, presenta nuevos datos sobre su gama de productos de hematología y tumores sólidos en el congreso anual de ASCO de 2024BASILEA, Suiza y PEKÍN y CAMBRIDGE, Massachusetts--(BUSINESS WIRE)--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), empresa internacional de oncología, ha anunciado hoy que compartirá los r... more »
-
Samenvatting: BeiGene, wereldwijde innovator op het gebied van oncologie, zet nieuwe gegevens over het hematologische en solide tumorportfolio in de schijnwerpers tijdens de jaarlijkse ASCO-bijeenkomst in 2024BASEL, Zwitserland & BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), een wereldwijd oncologiebedrijf, kondigde vandaag aan dat het onderzoeksres... more »
-
Hithium、BNEFサミット・ニューヨークで討論会を開催し、次世代バッテリー・エネルギー貯蔵システムについて議論ニューヨーク--(BUSINESS WIRE)--(ビジネスワイヤ) -- 4月16日から17日にかけて、ブルームバーグNEF(BNEF)サミットが米国ニューヨークで開催されました。BNEFサミットでは、エネルギー、金融、テクノロジーの専門家が一堂に会し、アイデアや見識のやりとりを通じて、交流を図ります。Hithiumは2023年に世界市場に進出後、今回が初参加となりました。また、Hithi... more »
-
TSMC feiert das 30. North America Technology Symposium mit Innovationen, die KI mit Silizium vorantreibenSANTA CLARA, Kalifornien--(BUSINESS WIRE)--TSMC (TWSE: 2330, NYSE: TSM) hat heute auf dem 2024 North America Technology Symposium des Unternehmens seine neuesten Halbleiterprozesse, fortschrittlich... more »
-
MindMed to Present at Upcoming May Medical ConferencesNEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain h... more »
-
Harrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that it will release its financial results for the first quarter ended March... more »
-
Ziff Davis to Participate in Two Investor Conferences in MayNEW YORK--(BUSINESS WIRE)--Ziff Davis, Inc. (NASDAQ: ZD), today announced its participation in two investor conferences in May. Details of the conferences are as follows: 19th Annual Needham Techno... more »
-
Mission Bio's New Translocation Analysis Offers Insights into Critical Safety Assessment for Gene-Edited Cell ProductsSOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mission Bio, a leader in single-cell multiomic solutions for precision medicine, today announced the launch of a new single-cell capability that enhanc... more »
-
SCIENCE CORPORATION ACQUIERT L’IMPLANT RÉTINAL PRIMA DE PIXIUM, RENFORÇANT ET DIVERSIFIANT AINSI SON ENGAGEMENT EN FAVEUR DE LA RESTAURATION DE LA VISION GRÂCE À SA TECHNOLOGIE D'INTERFACE NEURONALE DIRECTEALAMEDA, CALIFORNIE--(BUSINESS WIRE)--Science Corporation (« Science »), leader de la technologie d'interface neuronale directe (« IND ») et développeur de Science Eye, a fait l’acquisition des dro... more »
-
Science Corporation Acquires Pixium’s PRIMA Retinal Implant, Extending and Diversifying Its Commitment to Vision Restoration Through Brain-Computer Interface TechnologyALAMEDA, Calif.--(BUSINESS WIRE)--Science Corporation acquires Pixium's PRIMA retinal implant, diversifying commitment to vision restoration more »
-
Comcast Reports 1st Quarter 2024 ResultsPHILADELPHIA--(BUSINESS WIRE)--Comcast Corporation (NASDAQ: CMCSA) today reported results for the quarter ended March 31, 2024. “Our team is continuing to execute exceptionally well in a dynamic an... more »
-
Intevac Announces First Quarter 2024 Financial ResultsSANTA CLARA, Calif.--(BUSINESS WIRE)--Intevac, Inc. (Nasdaq: IVAC) today reported financial results for the first quarter ended March 30, 2024. Q1 Highlights: Continued strong demand for technology... more »